Effects of metformin and alogliptin on body composition in people with type 2 diabetes.
Yumie TakeshitaYuki KitaKen-Ichiro KatoTakehiro KanamoriHirofumi MisuShuichi KanekoToshinari TakamuraPublished in: Journal of diabetes investigation (2018)
Metformin and alogliptin exert opposite effects on bodyweight in type 2 diabetes patients who are overweight. The higher the BMI, the more metformin reduces bodyweight and alogliptin increases weight.
Keyphrases
- body composition
- type diabetes
- end stage renal disease
- weight gain
- body mass index
- resistance training
- weight loss
- ejection fraction
- chronic kidney disease
- physical activity
- bone mineral density
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- insulin resistance
- glycemic control
- adipose tissue
- skeletal muscle
- patient reported outcomes
- postmenopausal women
- patient reported